Supplementary Table 1.
Detailed clinical information for the DN and NDRD patients used for urinary protein microarray analysis
| Characteristics | DN (n = 15) | NDRD (n = 17) | ||
|---|---|---|---|---|
| DN group I (n = 7) | DN group II (n = 8) | MN (n = 9) | IgAN (n = 8) | |
| Age (years) | 58.9 ± 10.4 | 59.4 ± 9.4 | 57.6 ± 6.0 | 54.0 ± 10.4 |
| Sex (male/female) | 4/3 | 5/3 | 5/4 | 5/3 |
| BMI (kg/cm2) | 23.8 ± 2.0 | 25.7 ± 4.2 | 24.6 ± 3.2 | 24.2 ± 3.3 |
| Duration of diabetes (months)* | 121.0 (43.1) | 144.1 (78.1) | 69.2 (109.3) | 58.9 (88.3) |
| HbA1c (%) | 6.9 ± 1.2 | 7.2 ± 2.1 | 7.1 ± 2.0 | 6.7 ± 1.9 |
| Glucose (mmol/L) | 7.5 ± 1.3 | 7.8 ± 2.2 | 7.6 ± 1.7 | 7.1 ± 2.5 |
| Systolic blood pressure (mmHg) | 140.2 ± 18.9 | 144.6 ± 13.1 | 130.1 ± 12.0 | 134.2 ± 9.5 |
| Diastolic blood pressure (mmHg) | 81.9 ± 11.6 | 81.1 ± 10.1 | 81.6 ± 6.5 | 88.8 ± 9.7 |
| Urinary protein (g/24 h) | 1.9 ± 1.4 | 2.8 ± 1.6 | 3.3 ± 2.2 | 2.0 ± 1.8 |
| Blood urea nitrogen (mmol/L)* | 7.0 (2.9) | 8.7 (3.4) | 5.0 (2.1) | 7.0 (4.9) |
| Creatinine (µmol/L)* | 95.0 (38.0) | 154.5 (47.7) | 67.0 (35.7) | 105.8 (74.8) |
| eGFR (ml·min−1·1.73 m−2)* | 80.6 (30.7) | 41.8 (19.8) | 99.9 (29.5) | 58.8 (50.1) |
Variables following normal distribution are expressed with mean ± SD. *Variables following nonnormal distribution are expressed with the median. NDRD: Nondiabetic renal disease; DN: Diabetic nephropathy; SD: Standard deviation; MN: Membranous nephropathy; IgAN: IgA nephropathy; eGFR: Estimated glomerular filtration rate; BMI: Body mass index; HbA1c: Glycated hemoglobin.